Molecular basis of intestinal adaptation: The role of the insulin-like growth factor system

Annals of the New York Academy of Sciences

Volumn 859, Issue , 1998, Pages 18-36

  Lund, P Kay ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CYTOKINE; GROWTH FACTOR; GROWTH FACTOR RECEPTOR; GROWTH HORMONE; SOMATOMEDIN; SOMATOMEDIN C;

ADAPTATION; CONFERENCE PAPER; ENTEROPATHY; INTESTINE; MOLECULAR BIOLOGY; PROTEIN EXPRESSION; RISK BENEFIT ANALYSIS; SHORT BOWEL SYNDROME; SIGNAL TRANSDUCTION;

EID: 0032439773     PISSN: 00778923     EISSN: None     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.1998.tb11108.x     Document Type: Conference Paper

References (87)

1. 1. PODOLSKY, D. K. 1993. Regulation of intestinal epithelial proliferation: A few answers, many questions. Am. J. Physiol. 264: G179-G186.
2. 2. VANDERHOOF, J. A. 1996. Short bowel syndrome in children and small intestinal transplantation. Pediatr. Clin. North Am. 43: 533-550.
3. 3. JENKINS, A. P. & R. P. THOMPSON. 1994. Mechanisms of small intestinal adaptation. Digestive Dis. 12: 15-27.
4. 4. VANDERHOOF, J. A., A. N. LANGNAS, L. W. PINCH, J. S. THOMPSON & S. S. KAUFMAN. 1992. Short bowel syndrome. J. Pediatr. Gastroenterol. Nutr. 14: 359-370.
5. 5. NIGHTINGALE, J. M. & J. E. LENNARD-JONES. 1993. The short bowel syndrome: What's new and old? Digestive Dis. 11: 12-31.
6. 6. LUND, P. K. 1994. Insulin-like growth factors. In Gut Peptides: Biochemistry and Physiology. G. Dockray & J. H. Walsh, Eds.: 587-613. Raven Press. New York.
7. 7. TAYLOR, B., G. M. MURPHY & R. H. DOWLING. 1979. Pituitary hormones and the small bowel: Effect of hypophysectomy on intestinal adaptation to small bowel resection in the rat. Eur. J. Clin. Invest. 9: 115-127.
8. 8. VANDERHOOF, J. A., R. H. MCCUSKER, R. CLARK, H. MOHAMMADPOUR, D. J. BLACKWOOD & J. H. PARK. 1992. Truncated and native insulin like growth factor I enhance mucosal adaptation after jejunoileal resection. Gastroenterology 102: 1949-1956.
9. 9. CHAET, M. S., G. ARYA, M. M. ZIEGLER & B. W. WARNER. 1994. Epidermal growth factor enhances intestinal adaptation after massive small bowel resection. J. Pediatr. Surg. 29: 1035-1038.
10. 10. DRUCKER, D. J., P. ERLICH, S. L. ASA & P. L. BRUBAKER. 1996. Induction of intestinal epithelial proliferation by glucagon-like peptide 2. Proc. Natl. Acad. Sci. USA 93: 7911-7916.
11. 11. BYRNE, T. A., R. L. PERSINGER, L. S. YOUNG, T. R. ZIEGLER & D. W. WILMORE. 1995. A new treatment for patients with short-bowel syndrome. Growth hormone, glutamine, and a modified diet. Ann. Surg. 222: 243-54.
12. 12. LEINSKOLD, T., J. PERMERT, G. OLAISON & J. LARSSON. 1995. Effect of postoperative insulin-like growth factor I supplementation on protein metabolism in humans. Br. J. Surg. 82: 921-925.
13. 13. Clemmons, D. R. & L. E. Underwood. 1994. Clinical review 59: Uses of human insulin-like growth factor-I in clinical conditions. J. Clin. Endocrinol. Metab. 79: 4-6.
14. 14. POTTEN, C. S. 1992. The significance of spontaneous and induced apoptosis in the gastrointestinal tract of mice. Cancer Metast. Rev. 11: 179-195.
15. 15. QUE, F. G. & G. J. GORES. 1996. Cell death by apoptosis: basic concepts and disease relevance for the gastroenterologist [see comments]. Gastroenterology 110: 1238-1243.
16. 16. SINGH, P., B. DAI, C. YALLAMPALLI & Z. XU. 1994. Expression of IGF-II and IGF-binding proteins by colon cancer cells in relation to growth response to IGFs. Am. J. Physiol. 267: G608-G617.
17. 17. LOUVARD, D., M. KEDINGER & H. P. HAURI. 1992. The differentiating intestinal epithelial cell: Establishment and maintenance of functions through interactions between cellular structures. Ann. Rev. Cell Biol. 8: 157-195.
18. 18. SIMON-ASSMANN, P. & M. KEDINGER. 1993. Heterotypic cellular cooperation in gut morphogenesis and differentiation. Semin. Cell Biol. 4: 221-230.
19. 19. SIMON-ASSMANN, P., M. KEDINGER, A. DE ARCANGELIS, V. ROUSSEAU & P. SIMO. 1995. Extracellular matrix components in intestinal development. Experientia 51: 883-900.
20. 20. SANDERSON, I. R., R. M. EZZELL, M. KEDINGER, M., et al. 1996. Human fetal enterocytes in vitro: Modulation of the phenotype by extracellular matrix. Proc. Natl. Acad. Sci. USA 93: 7717-7722.
21. 21. Lund, P. K., B. M. Moats-Staats, M. A. Hynes, et al. 1986. Somatomedin-C/insulin-like growth factor-T and insulin-like growth factor-II mRNAs in rat fetal and adult tissues. J. Biol. Chem. 261: 14539-14544.
22. 22. HAN, V. K., A. J. D'ERCOLE & P. K. LUND. 1987. Cellular localization of somatomedin (insulin-like growth factor) messenger RNA in the human fetus. Science 236: 193-197.
23. 23. QUARONI, A., J. WANDS, R. L. TRELSTAD & K. J. ISSELBACHER. 1979. Epithelioid cell cultures from rat small intestine. Characterization by morphologic and immunologic criteria. J. Cell Biol. 80: 248-265.
24. 24. SIMMONS, J. G., E. C. HOYT, J. K. WESTWICK, D. A. BRENNER, J. B. PUCILOWSKA, & P. K. LUND. 1995. Insulin-like growth factor-I and epidermal growth factor interact to regulate growth and gene expression in IEC-6 intestinal epithelial cells. Mol. Endocrinol. 9: 1157-1165.
25. 25. KUROKOWA, M., K. LYNCH & D. K. PODOLSKY. 1987. Effects of growth factors on an intestinal epithelial cell line: Transforming growth factor beta inhibits proliferation and stimulates differentiation. Biochem. Biophys. Res. Commun. 142: 775-782.
26. 26. CARROL, K. M., T. T. WONG, D. L. DRABIK & E. B. CHANG. 1988. Differentiation of rat small intestine epithelial cells by extracellular matrix. Am. J. Physiol. 254: G355-G360.
27. 27. HE, Y., S. H. CHU & W. A. WALKER. 1993. Nucleotide supplements alter proliferation and differentiation of cultured human (Caco-2) and rat (IEC-6) intestinal epithelial cells. J. Nutr. 123: 1017-1027.
28. 28. SUH, E. & P. G. TRABER. 1996. An intestine-specific homeobox gene regulates proliferation and differentiation. Mol. & Cell. Biol. 16: 619-625.
29. 29. PAUL EILEEN, C. A., J. HOCHMAN & A. QUARONI. 1993. Conditionally immortalized intestinal epithelial cells: Novel approach for study of differentiated enterocytes. Am. J. Physiol. 265: C266-C278.
30. 30. WHITEHEAD, R. H., P. E. VANEEDEN, M. D. NOBLE, P. ATALIOTIS & P. S. JAT. 1993. Establishment of conditionally immortalized epithelial cell lines from both colon and small intestine of adult H-2Kb-tsA58 transgenic mice Proc. Natl. Acad. Sci. USA 90: 587-591.
31. 31. HALTTUNEN, T., A. MARTTINEN, I. RANTALA, H. KAINULAINEN & M. MAKI. 1996. Fibroblasts and transforming growth factor β induce organization and differentiation of T84 human epithelial cells. Gastroenterology 111: 1252-1262.
32. 32. SONNENBERG, E., D. MEYER, K. M. WEIDNER & C. BIRCHMEIER. 1993. Scatter factor/hepatocyte growth factor and its receptor, the c-met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development. J. Cell Biol. 123(1): 223-235.
33. 33. FRITSCH, C., P. SIMON-ASSMANN, M. KEDINGER & G. S. EVANS. 1997. Cytokines modulate fibroblast phenotype and epithelial-stroma interactions in rat intestine. Gastroenterology 112: 826-838.
34. 34. SIMMONS, J. G., J. PUCILOWSKA & P. K. LUND. 1997. Insulin-like growth factor-II (IGF-II) expressed by intestinal fibroblasts is a potent mitogen for intestinal epithelial cells. Gastroenteroloy 112: A906.
35. 35. PUCILOWSKA, J., J. G. SIMMONS, R. B. SARTOR & P. K. LUND. 1997. IGF-I and TGF-β have different effects on phenotype and proliferation of intestinal fibroblasts: A potential role of IGF binding proteins (IGFBPs). Gastroenterology 112: A1064.
36. 36. VALENTICH, J. D., V. POPOV, J. I. SAADA & D. W. POWELL. 1997. Phenotypic characterization of an intestinal subepithelial myofibroblast cell line. Am. J. Physiol. 272: C1513-C1524.
37. 37. VAN TOL, E. A. F., F. M. KONG, R. RIPPE, M. YAMAUCHI, P. K. LUND & R. B. SARTOR. 1998. Bacterial cell wall polymers promote intestinal fibrosis by direct stimulation of myofibroblasts. Am. J. Physiol. In press.
38. 38. JONES, J. I. & D. R. CLEMMONS. 1995. Insulin-like growth factors and their binding proteins: Biological actions. Endocr. Rev. 16: 3-34.
39. 39. MOHAPATRA, N. K., M. H. ULSHEN, C. R. FULLER, E. M. ZIMMERMANN, K. HALDEMAN & P. K. LUND. 1995. Cell specific expression and regulation of insulin-like growth factor I (IGF-I) and IGF binding proteins (IGFBPs) during adaptive growth of small intestine. Endocr. Soc. Abstr. No. OR37-5.
40. 40. WINESETT, D. E., M. H. ULSHEN, E. C. HOYT, N. K. MOHAPATRA, C. R. FULLER & P. K. LUND. 1995. Regulation and localization of the insulin-like growth factor system in small bowel during altered nutrient status. Am. J. of Physiol. 268: G631-G640.
41. 41. VALENTINIS, B., A. BHALA, T. DEANGELIS, R. BASERGA & P. COHEN. 1995. The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene. Mol. Endocrinol. 9: 361-367.
42. 42. ULSHEN, M. H., R. H. DOWLING, C. R. FULLER, E. M. ZIMMERMANN & P. K. LUND. 1993. Enhanced growth of small bowel in transgenic mice overexpressing bovine growth hormone [see comments]. Gastroenterology 104: 973-980.
43. 43. LEMMEY, A. B., A. A. MARTIN, L. C. READ, F. M. TOMAS, P. C. OWENS & F. J. BALLARD. 1991. IGF-I and the truncated analogue des-(1-3)IGF-I enhance growth in rats after gut resection. Am. J. Physiol. 260: E213-E219.
44. 44. MANTELL, M. P., T. R. ZIEGLER, W. T. ADAMSON, et al. 1995. Resection-induced colonic adaptation is augmented by IGF-I and associated with upregulation of colonic IGF-I mRNA. Am. J. Physiol. 269: G974-G980.
45. 45. ZHANG, W., W. L. FRANKEL, W. T. ADAMSON, et al. 1995. Insulin-like growth factor-I improves mucosal structure and function in transplanted rat small intestine. Transplantation 59: 755-761.
46. 46. LO, H. C. & D. M. NEY. 1996. GH and IGF-I differentially increase protein synthesis in skeletal muscle and jejunum of parenterally fed rats. Am. J. Physiol. 271: E872-E878.
47. 47. PETERSON, C. A., H. V. CAREY, P. L. HINTON, H. C. LO & D. M. NEY. 1997. GH elevates serum IGF-I levels but does not alter mucosal atrophy in parenterally fed rats. Am. J. Physiol. 272: G1100-G1108.
48. 48. YANG, H., D. M. NEY, C. A. PETERSON, H. C. LO, H. V. CAREY & M. L. ADAMO. 1997. Stimulation of intestinal growth is associated with increased insulin-like growth factor-binding protein 5mRNA in the jejunal mucosa of insulin like growth-factor I-treated parenterally fed rats. Proc. Soc. Exp. Biol. Med. 216: 438-445.
49. 49. MANTELL, M. P., T. R. ZIEGLER, R. J. SMITH & J. R. ROMBEAU. 1993. Regulation of the intestinal insulin-like growth factor (IGF-I) action pathway after massive small bowel resection and IGF-I administration. Surg. Forum 44: 1.
50. 50. LUND, P. K., D. ROUNTREE, S. E. SELUB & M. H. ULSHEN. 1990. Molecular biology of gastrointestinal peptides and growth factors: Relevance for mucosal growth and adaptation. Digestion 46 (S2): 66-73.
51. 51. ALBISTON, A. L., R. G. TAYLOR, A. C. HERINGTON, D. J. BEVERIDGE & P. J. FULLER. 1992. Divergent ileal IGF-I and IGFBP-3 gene expression after small bowel resection: A novel mechanism to amplify IGF action? Mol. Cell. Endocrinol. 83: R17-R20.
52. 52. SAVENDAHL, L., L. E. UNDERWOOD, K. M. HALDEMAN, P. K. LUND. 1997. Fasting prevents experimental murine colitis produced by dextran sulfate sodium and decreases interleukin-1b and insulin-like growth factor-I messenger RNA. Endocrinology 138: 734-740.
53. 53. LUND, P. K. & E. M. ZIMMERMANN. 1996. Insulin-like growth factors and inflammatory disease. In: Cytokines and Growth Factors in Gastroenterology. R. Goodlad & N. Wright. Eds.: 83-96. Bailliere's Clinical Gastroenterology. London.
54. 54. ZIMMERMANN, E., B. SARTOR, R. D. MCCALL, M. PARDO & P. K. LUND. 1993. IGF-I and IL-Iβ in a rat model of granulomatous enterocolitis and hepatitis. Gastroenterology 105: 399-409.
55. 55. ZIMMERMANN, E. M., K. MCNAUGHTON, R. B. SARTOR & P. K. LUND. 1993. IGF-I is overexpressed in cells with a smooth muscle phenotype in peptidoglycan-polysaccharide induced chronic enterocolitis in the rat. AGA Abstracts 104(4): A808.
56. 56. WANG, J., W. NIU, Y. NIKIFOROV, et al. 1997. Targeted overexpression of IGF-I evokes distinct patterns of organ remodeling in smooth muscle cell tissue beds of transgenic mice. J. Clin. Invest. 100: 1425-1439.
57. 57. LUND, P. K. 1998. The alpha-smooth muscle actin promoter: A useful tool to analyze autocrine and paracrine roles of mesenchymal cells in normal and diseased bowel. Gut 42: 320-322.
58. 58. OHNEDA, K., M. H. ULSHEN, C. R. FULLER, A. J. D'ERCOLE & P. K. LUND. 1997. Enhanced growth of small bowel in transgenic mice expressing human insulin-like growth factor I. Gastroenterology 112: 444-454.
59. 59. ULSHEN, M. H., C. R. FULLER & P. K. LUND. 1995. Effects of excess growth hormone (GH) on small bowel growth in weanling transgenic mice. Gastroenterology 108: A759-A750.
60. 60. RUBIN, R. & R. BASERGA. 1995. Insulin-like growth factor-I receptor. Its role in cell proliferation, apoptosis, and tumorigenicity. Lab. Invest. 73: 311-331.
61. 61. DE MEYTS, P., B. WALLACH, C. T. CHRISTOFFERSEN, et al. 1994. The insulin-like growth factor-I receptor. Structure, ligand-binding mechanism and signal transduction. Horm. Res. 42: 152-169.
62. 62. BAKER, J., J. P. LIU, E. J. ROBERTSON & A. EFSTRATIADIS. 1993. Role of insulin-like growth factors in embryonic and postnatal growth. Cell 75: 73-82.
63. 63. MEYER, D. J., G. S. CAMPBELL, B. H. COCHRAN, et al. 1994. Growth hormone induces a DNA binding factor related to the interferon-stimulated 91-kDa transcription factor. J. Bio. Chem. 269: 4701-4704.
64. 64. SUN, X. J., L. M. WANG, Y. ZHANG, et al. 1995. Role of IRS-2 in insulin and cytokine signaling. Nature 377: 173-177.
65. 65. UENO, H., N. HIRANO, H. KOZUTSUMI, et al. 1995. An epidermal growth factor receptor-leukocyte tyrosine kinase chimeric receptor generates ligand-dependent growth signals through the Ras signaling pathway. J. Biol. Chem. 270: 20135-20142.
66. 66. UENO, H., K. SASAKI, H. KOZUTSUMI, et al. 1996. Growth and survival signals transmitted via two distinct NPXY motifs within leukocyte tyrosine kinase, an insulin receptor-related tyrosine kinase. J. of Biol. Chem. 271: 27707-27714.
67. 67. MILARSKI, K. L. & A. R. SALTIEL. 1994. Expression of catalytically inactive Syp phosphatase in 3T3 cells blocks stimulation of mitogen-activated protein kinase by insulin. J. Biol. Chem. 269: 21239-21243.
68. 68. SUN, X. J., S. PONS, T. ASANO, M. G. MYERS, JR., E. GLASHEEN & M. F. WHITE. 1996. The Fyn tyrosine kinase binds Irs-1 and forms a distinct signaling complex during insulin stimulation. J. Biol. Chem. 271: 10583-10587.
69. 69. BEITNER-JOHNSON, D., V. A. BLAKESLEY, Z. SHEN-ORR, et al. 1996. The proto-oncogene product c-Crk associates with insulin receptor substrate-1 and 4PS. Modulation by insulin growth factor-I (IGF) and enhanced IGF-I signaling. J. Biol. Chem. 271: 9287-9290.
70. 70. VAN DER GEER, P., T. HUNTER & R. A. LINDBERG. 1994. Receptor protein-tyrosine kinases and their signal transduction pathways. Ann. Rev. Cell Biol. 10: 251-337.
71. 71. HADDAD, T. C. & C. A. CONOVER. 1997. Insulin and interleukin-4 induce desensitization to the mitogenic effects of insulin-like growth factor-I - Pivotal role for insulin receptor substrate-2. J. Biol. Chem. 272: 19525-19531.
72. 72. UENO, H., H. HONDA, T. NAKAMOTO, et al. 1997. The phosphatidylinositol 3′ kinase pathway is required for the survival signal of leukocyte tyrosine kinase. Oncogene 14: 3067-3072.
73. 73. SUN, X. J., S. PONS, L. M. WANG, et al. 1997. The IRS-2 gene on murine chromosome 8 encodes a unique signaling adapter for insulin and cytokine action. Mol. Endocrinol. 11: 251-262.
74. 74. SHARFE, N. & C. M. ROIFMAN. 1997. Differential association of phosphatidylinositol 3-kinase with insulin receptor substrate (IRS)-1 and IRS-2 in human thymocytes in response to IL-7. J. Immunol. 159: 1107-1114.
75. 75. PERALDI, P., G. S. HOTAMISLIGIL, W. A. BUURMAN, M. F. WHITE & B. M. SPIEGELMAN. 1996. Tumor necrosis factor (TNF)-alpha inhibits insulin signaling through stimulation of the p55 TNF receptor and activation of sphingomyelinase. J. Biol. Chem. 271: 13018-13022.
76. 76. POSTEL-VINAY, M. C. & J. FINIDORI. 1995. Growth hormone receptor: structure and signal transduction. Eur. J. Endocrinol. 133: 654-659.
77. 77. SMITH, T. R., J. S. ELMENDORF, T. S. DAVID & J. TURINSKY. 1997. Growth hormone-induced insulin resistance - role of the insulin receptor, IRS-1, GLUT-1, and GLUT-4. Am. J. Physiol. 35: E1071-E1079.
78. 78. KILGOUR, E., I. GOUT & N. G. ANDERSON. 1996. Requirement for phosphoinositide 3-OH kinase in growth hormone signaling to the mitogen-activated protein kinase and p70s6k pathways. Biochem. J. 315: 517-522.
79. 79. RICORT, J. M., J. F. TANTI, E. VANOBBERGHEN & Y. LAMARCHANDBRUSTEL. 1997. Cross-talk between the platelet-derived growth factor and the insulin signaling pathways in 3T3-L1 adipocytes. J. Biol. Chem. 272: 19814-19818.
80. 80. ARAKI, E., M. A. LIPES, M. E. PATTI, J. C. BRUNING, B. HAAG & R. S. JOHNSON. 1994. Alternative pathway of insulin signaling in mice with targeted disruption of the IRS-1 gene. Nature 372: 186-190.
81. 81. MERLO, G. R., F. BASOLO, L. FIORE, L. DUBOC & N. E. HYNES. 1995. P53-dependent and p53-independent activation of apoptosis in mammary epithelial cells reveals a survival function of EGF and insulin. J. Cell Biol. 128: 1185-1196.
82. 82. CHRISTOFORI, G., P. NAIK & D. HANAHAN. 1994. A second signal supplied by insulin-like growth factor II in oncogene-induced tumorigenesis. Nature 369: 414-418.
83. 83. WONG, B. C., N. M. MICHELL, M. J. LANGMAN & M. C. EGGO. 1996. Induction of apoptosis by protein kinase C-B1 activator in colon-205 human colonic carcinoma cells and its prevention by insulin-like growth factor I. Gastroenterology 110: A615-A610.
84. 84. WONG, B. C., N. M. MICHELL, M. J. LANGMAN & M. C. EGGO. 1996. Insulin-like growth factor I protects human colonic cancer cells from indomethacin induced apoptosis. Gastroenterology 110: A615-A610.
85. 85. WILLIAMS, K. L., K. OHNEDA, C. R. FULLER & P. K. LUND. 1998. Differential effects of chronic IGF-I and GH excess on apoptosis in the small intestine. Endoc. Soc. Abstr. No. OR26-4.
86. 86. ZIMMERMANN, E. M., L. LI, Y. T. HOU, M. CANNON, G. M. CHRISTMAN & K. N. BITAR. 1997. Insulin-like growth factor-I induces collagen and insulin-like growth factor binding protein-5 mRNAs in rat intestinal smooth muscle. Am. J. Physiol. 273: G875-882.
87. 87. PINTAR, J. E., J. A. CERRO & T. L. WOOD. 1996. Genetic approaches to the function of insulin-like growth factor-binding proteins during rodent development. Horm. Res. 45: 172-177.